| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |




*Max-Delbrück-Center (MDC) for Molecular Medicine, HELIOS-Klinikum-Berlin, Franz Volhard Clinic, Medical Faculty of the Charité,
Humboldt University, Berlin, Germany.
Correspondence to Dr. Friedrich C. Luft, Franz Volhard Clinic, Wiltbergstrasse 50 13125 Berlin, Germany. Phone: 49-30-9417-2202; Fax: 49-30-9417-2206;
ABSTRACT. AT2 receptor-disrupted (AT2 -/-) mice provide a unique opportunity to investigate the cardiovascular and BP-related effects of NO depletion. This study compared the pressure-diuresis-natriuresis relationship in (AT2 -/-) and wild-type (AT2 +/+) mice after treating the animals with L-NAME (130 mg/kg body wt per day) for 1 wk. L-NAME increased mean arterial pressure (MAP) more in AT2 -/- than in AT2 +/+ mice (118 ± 2 versus 108 ± 4 mmHg). This difference occurred even though L-NAMEtreated AT2 +/+ mice had a greater sodium excretion than AT2 -/- mice (10.9 ± 0.5 versus 8.0 ± 1.0 µmol/h). The pressure-natriuresis relationship in conscious AT2 -/- mice was shifted rightward compared with controls. RBF was decreased in AT2 -/- compared with AT2 +/+ mice. L-NAME decreased RBF in these mice further from 4.08 ± 0.43 to 2.79 ± 0.15 ml/min per g of kidney wt. GFR was not significantly different between AT2 +/+ and AT2 -/- mice (1.09 ± 0.08 versus 1.21 ± 0.09 ml/min per g of kidney wt). L-NAME reduced GFR in AT2 -/- to 0.87 ± 0.07 ml/min per g of kidney wt. Fractional sodium (FENa) and water (FEH2O) curves were shifted more strongly to the right by L-NAME in AT2 -/- mice than in AT2 +/+ mice. AT1 receptor blocker treatment lowered BP in both L-NAMEtreated strains to basal values. It is concluded that the AT1 receptor plays a key role in the impaired renal sodium and water excretion induced by NO synthesis blockade. Changes in RBF, GFR, and tubular sodium and water reabsorption are involved and may be also responsible for the greater BP increase in L-NAMEtreated AT2 -/- mice. E-mail: luft@fvk-berlin.de
This article has been cited by other articles:
![]() |
M. Z. Haque and D. S. A. Majid Reduced renal responses to nitric oxide synthase inhibition in mice lacking the gene for gp91phox subunit of NAD(P)H oxidase Am J Physiol Renal Physiol, September 1, 2008; 295(3): F758 - F764. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Fitzgerald, B. K. Kemp-Harper, H. C. Parkington, G. A. Head, and R. G. Evans Endothelial dysfunction and arterial pressure regulation during early diabetes in mice: roles for nitric oxide and endothelium-derived hyperpolarizing factor Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R707 - R713. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Shariat-Madar, F. Mahdi, M. Warnock, J. W. Homeister, S. Srikanth, Y. Krijanovski, L. J. Murphey, A. A. Jaffa, and A. H. Schmaier Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin Blood, July 1, 2006; 108(1): 192 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Obst, J. Tank, R. Plehm, K. J. Blumer, A. Diedrich, J. Jordan, F. C. Luft, and V. Gross NO-dependent blood pressure regulation in RGS2-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1012 - R1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bove, Z. Yang, W. D. Gilson, F. H. Epstein, B. A. French, S. S. Berr, S. P. Bishop, H. Matsubara, R. M. Carey, and C. M. Kramer Nitric Oxide Mediates Benefits of Angiotensin II Type 2 Receptor Overexpression During Post-Infarct Remodeling Hypertension, March 1, 2004; 43(3): 680 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Zhou, A. G. Adam, E. A. Jaimes, and L. Raij In Salt-Sensitive Hypertension, Increased Superoxide Production Is Linked to Functional Upregulation of Angiotensin II Hypertension, November 1, 2003; 42(5): 945 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Carey and H. M. Siragy Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation Endocr. Rev., June 1, 2003; 24(3): 261 - 271. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673